New York, New York and Geneva,
Switzerland
April, 2005
Highlights
The debate about
biotechnology applied to agriculture is one of the most vocal
and passionate debates that have been taking place in recent
years. This is probably the consequence of the diverging
appreciation that people and Governments have of the actual or
potential risks and benefits that the products of agricultural
biotechnology - genetically modified organisms (GMOs) and
products thereof - can bring.
For some, they
would help addressing some of the most serious problems that
people, especially poor people in developing countries, face,
such as starvation and malnutrition. For others, they could
create serious and unpredictable health and environmental
problems and also have negative economic repercussions, in
particular in developing countries.
The proliferation
of domestic biosafety schemes and the related authorization,
labelling, traceability and documentation obligations are likely
to further complicate international trade in genetically
modified agricultural products and indirectly affect trade in
conventional agricultural products.
For developing
countries, agro-biotechnology is a particularly challenging
phenomenon. They could be the main beneficiaries of it - if
indeed agro-biotechnology keeps its promises - but they could
also be the main losers if agro-biotechnology negatively affects
biodiversity or if patented biotechnology disrupts traditional
practices among farmers and makes access to seeds more
difficult.
Countries are free
to decide how to deal with agro-biotechnology and biosafety at
the national level, but domestic legislation has to be
WTO-consistent to the extent that it affects international
trade. At the same time, this is a field where multilateral
rules have been agreed upon in a separate legal instrument, the
Cartagena Protocol on Biosafety. The interaction between this
specific instrument and the WTO rules adds challenges to an
already complex scenario.
While developed
countries have established their national frameworks to deal
with agro-biotechnology and biosafety focusing primarily on
domestic priorities and strategies, most developing countries
are doing so under less flexible circumstances. They
increasingly seem to be expected to set up their national
regulatory schemes based on the requests and expectations of
their main trade partners. For developing countries, reconciling
their trade interests with their responsibility for improving
the quantity and quality of agricultural and food products made
available to the population and with their commitment to
environmental preservation is proving to be a difficult task.
Full report in PDF
format:
www.unctad.org/en/docs/itcdtab30_en.pdf |